Report Content
Chapter 1 Methodology & Scope
1.1 Methodology
1.2 Base estimates and working
1.2.1 North America
1.2.2 Europe
1.2.3 Asia Pacific
1.2.4 Latin America
1.2.5 MEA
1.3 Forecast parameters
1.4 Data validation
1.5 Data sources
1.5.1 Secondary
1.5.1.1 Paid sources
1.5.1.2 Public sources
1.5.2 Primary
Chapter 2 Executive Summary
2.1 Biopreservation market industry 360° synopsis, 2017 - 2030
2.1.1 Business trends
2.1.2 Product trends
2.1.3 Application trends
2.1.4 Cell provider trends
2.1.5 Regional trends
Chapter 3 Biopreservation Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2017 - 2030
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Increasing investment in R&D
3.3.1.2 Rising healthcare expenditure
3.3.1.3 Advancement in biopreservation applications
3.3.1.4 Growing demand for regenerative medicine owing to rising prevalence of lifestyle diseases
3.3.2 Industry pitfalls & challenges
3.3.2.1 Requirement of room temperature storage technology
3.3.2.2 Stringent regulations pertaining to biopreservation
3.4 Growth potential analysis
3.4.1 By product
3.4.2 By application
3.4.3 By cell provider
3.5 COVID- 19 impact analysis
3.6 Porter's analysis
3.6.1 Bargaining power of suppliers
3.6.2 Bargaining power of buyers
3.6.3 Threat of new entrants
3.6.4 Threat of substitutes
3.7 Recent advancements in biopreservation
3.8 Legal and ethical guidelines for biopreservation
3.9 Applications of biopreservation
3.9.1 Stem cell preservation
3.9.2 Regenerative medicine
3.10 Top 10 stem cell banking companies
3.10.1 Average annual fee of stem cell banking
3.11 Competitive landscape, 2021
3.12 PESTEL analysis
Chapter 4 Biopreservation Market, By Product
4.1 Key segment trends
4.2 Equipment
4.2.1 Market size, by region, 2017 - 2030 (USD Million)
4.2.2 Freezers
4.2.2.1 Market size, by region, 2017-2030 (USD Million)
4.2.3 Refrigerators
4.2.3.1 Market size, by region, 2017 - 2030 (USD Million)
4.2.4 Consumables
4.2.4.1 Market size, by region, 2017-2030 (USD Million)
4.2.4.2 Vials
4.2.4.2.1 Market size, by region, 2017– 2030 (USD Million)
4.2.4.3 Straws
4.2.4.3.1 Market size, by region, 2017– 2030 (USD Million)
4.2.4.4 Microtiters
4.2.4.4.1 Market size, by region, 2017– 2030 (USD Million)
4.2.4.5 Bags
4.2.4.5.1 Market size, by region, 2017– 2030 (USD Million)
4.2.5 Liquid nitrogen
4.2.5.1 Market size, by region, 2017– 2030 (USD Million)
4.3 Media
4.3.1 Market size, by region, 2017– 2030 (USD Million)
4.3.2 Preformulated
4.3.2.1 Market size, by region, 2017– 2030 (USD Million)
4.3.3 Home-brew
4.3.3.1 Market size, by region, 2017– 2030 (USD Million)
4.4 Laboratory information management systems (LIMS)
4.4.1.1 Market size, by region, 2017– 2030 (USD Million)
Chapter 5 Biopreservation Market, By Application
5.1 Key segment trends
5.2 Regenerative medicine
5.2.1 Market size, by region, 2017 - 2030 (USD Million)
5.2.2 Cell therapy
5.2.2.1 Market size, by region, 2017– 2030 (USD Million)
5.2.3 Gene therapy
5.2.3.1 Market size, by region, 2017– 2030 (USD Million)
5.2.4 Others
5.2.4.1 Market size, by region, 2017– 2030 (USD Million)
5.3 Biobanking
5.3.1 Market size, by region, 2017 - 2030 (USD Million)
5.3.2 Human eggs
5.3.2.1 Market size, by region, 2017– 2030 (USD Million)
5.3.3 Human sperm
5.3.3.1 Market size, by region, 2017– 2030 (USD Million)
5.3.4 Veterinary IVF
5.3.4.1 Market size, by region, 2017– 2030 (USD Million)
5.4 Drug discovery
5.4.1 Market size, by region, 2017– 2030 (USD Million)
Chapter 6 Biopreservation Market, By Cell Provider
6.1 Key segment trends
6.2 CD34+
6.2.1 Market size, by region, 2017– 2030 (USD Million)
6.3 CD19+
6.3.1 Market size, by region, 2017– 2030 (USD Million)
6.4 MSC
6.4.1 Market size, by region, 2017– 2030 (USD Million)
6.5 iPSC
6.5.1 Market size, by region, 2017– 2030 (USD Million)
6.6 hESC
6.6.1 Market size, by region, 2017– 2030 (USD Million)
6.7 Tumor cells
6.7.1 Market size, by region, 2017– 2030 (USD Million)
6.8 Others
6.8.1 Market size, by region, 2017– 2030 (USD Million)
Chapter 7 Biopreservation Market, By Region
7.1 Key regional trends
7.2 North America
7.2.1 Market size, by country, 2017 - 2030 (USD Million)
7.2.2 Market size, by product, 2017 - 2030 (USD Million)
7.2.2.1 Market size by equipment, 2017– 2030 (USD Million)
7.2.2.1.1 Market size by consumables, 2017– 2030 (USD Million)
7.2.2.2 Market size by media, 2017– 2030 (USD Million)
7.2.3 Market size, by application, 2017 - 2030 (USD Million)
7.2.3.1 Market size by regenerative medicine, 2017– 2030 (USD Million)
7.2.3.2 Market size by biobanking, 2017– 2030 (USD Million)
7.2.4 Market size, by cell provider, 2017 - 2030 (USD Million)
7.2.5 U.S.
7.2.5.1 Market size, by product, 2017 - 2030 (USD Million)
7.2.5.1.1 Market size by equipment, 2017– 2030 (USD Million)
7.2.5.1.1.1 Market size by consumables, 2017– 2030 (USD Million)
7.2.5.1.2 Market size by media, 2017– 2030 (USD Million)
7.2.5.2 Market size, by application, 2017 - 2030 (USD Million)
7.2.5.2.1 Market size by regenerative medicine, 2017– 2030 (USD Million)
7.2.5.2.2 Market size by biobanking, 2017– 2030 (USD Million)
7.2.5.3 Market size, by cell provider, 2017 - 2030 (USD Million)
7.2.6 Canada
7.2.6.1 Market size, by product, 2017 - 2030 (USD Million)
7.2.6.1.1 Market size by equipment, 2017– 2030 (USD Million)
7.2.6.1.1.1 Market size by consumables, 2017– 2030 (USD Million)
7.2.6.1.2 Market size by media, 2017– 2030 (USD Million)
7.2.6.2 Market size, by application, 2017 - 2030 (USD Million)
7.2.6.2.1 Market size by regenerative medicine, 2017– 2030 (USD Million)
7.2.6.2.2 Market size by biobanking, 2017– 2030 (USD Million)
7.2.6.3 Market size, by cell provider, 2017 - 2030 (USD Million)
7.3 Europe
7.3.1 Market size, by country, 2017 - 2030 (USD Million)
7.3.2 Market size, by product, 2017 - 2030 (USD Million)
7.3.2.1 Market size by equipment, 2017– 2030 (USD Million)
7.3.2.1.1 Market size by consumables, 2017– 2030 (USD Million)
7.3.2.2 Market size by media, 2017– 2030 (USD Million)
7.3.3 Market size, by application, 2017 - 2030 (USD Million)
7.3.3.1 Market size by regenerative medicine, 2017– 2030 (USD Million)
7.3.3.2 Market size by biobanking, 2017– 2030 (USD Million)
7.3.4 Market size, by cell provider, 2017 - 2030 (USD Million)
7.3.5 Germany
7.3.5.1 Market size, by product, 2017 - 2030 (USD Million)
7.3.5.1.1 Market size by equipment, 2017– 2030 (USD Million)
7.3.5.1.1.1 Market size by consumables, 2017– 2030 (USD Million)
7.3.5.1.2 Market size by media, 2017– 2030 (USD Million)
7.3.5.2 Market size, by application, 2017 - 2030 (USD Million)
7.3.5.2.1 Market size by regenerative medicine, 2017– 2030 (USD Million)
7.3.5.2.2 Market size by biobanking, 2017– 2030 (USD Million)
7.3.5.3 Market size, by cell provider, 2017 - 2030 (USD Million)
7.3.6 UK
7.3.6.1 Market size, by product, 2017 - 2030 (USD Million)
7.3.6.1.1 Market size by equipment, 2017– 2030 (USD Million)
7.3.6.1.1.1 Market size by consumables, 2017– 2030 (USD Million)
7.3.6.1.2 Market size by media, 2017– 2030 (USD Million)
7.3.6.2 Market size, by application, 2017 - 2030 (USD Million)
7.3.6.2.1 Market size by regenerative medicine, 2017– 2030 (USD Million)
7.3.6.2.2 Market size by biobanking, 2017– 2030 (USD Million)
7.3.6.3 Market size, by cell provider, 2017 - 2030 (USD Million)
7.3.7 Italy
7.3.7.1 Market size, by product, 2017 - 2030 (USD Million)
7.3.7.1.1 Market size by equipment, 2017– 2030 (USD Million)
7.3.7.1.1.1 Market size by consumables, 2017– 2030 (USD Million)
7.3.7.1.2 Market size by media, 2017– 2030 (USD Million)
7.3.7.2 Market size, by application, 2017 - 2030 (USD Million)
7.3.7.2.1 Market size by regenerative medicine, 2017– 2030 (USD Million)
7.3.7.2.2 Market size by biobanking, 2017– 2030 (USD Million)
7.3.7.3 Market size, by cell provider, 2017 - 2030 (USD Million)
7.3.8 UK
7.3.8.1 Market size, by product, 2017 - 2030 (USD Million)
7.3.8.1.1 Market size by equipment, 2017– 2030 (USD Million)
7.3.8.1.1.1 Market size by consumables, 2017– 2030 (USD Million)
7.3.8.1.2 Market size by media, 2017– 2030 (USD Million)
7.3.8.2 Market size, by application, 2017 - 2030 (USD Million)
7.3.8.2.1 Market size by regenerative medicine, 2017– 2030 (USD Million)
7.3.8.2.2 Market size by biobanking, 2017– 2030 (USD Million)
7.3.8.3 Market size, by cell provider, 2017 - 2030 (USD Million)
7.3.9 France
7.3.9.1 Market size, by product, 2017 - 2030 (USD Million)
7.3.9.1.1 Market size by equipment, 2017– 2030 (USD Million)
7.3.9.1.1.1 Market size by consumables, 2017– 2030 (USD Million)
7.3.9.1.2 Market size by media, 2017– 2030 (USD Million)
7.3.9.2 Market size, by application, 2017 - 2030 (USD Million)
7.3.9.2.1 Market size by regenerative medicine, 2017– 2030 (USD Million)
7.3.9.2.2 Market size by biobanking, 2017– 2030 (USD Million)
7.3.9.3 Market size, by cell provider, 2017 - 2030 (USD Million)
7.3.10 Spain
7.3.10.1 Market size, by product, 2017 - 2030 (USD Million)
7.3.10.1.1 Market size by equipment, 2017– 2030 (USD Million)
7.3.10.1.1.1 Market size by consumables, 2017– 2030 (USD Million)
7.3.10.1.2 Market size by media, 2017– 2030 (USD Million)
7.3.10.2 Market size, by application, 2017 - 2030 (USD Million)
7.3.10.2.1 Market size by regenerative medicine, 2017– 2030 (USD Million)
7.3.10.2.2 Market size by biobanking, 2017– 2030 (USD Million)
7.3.10.3 Market size, by cell provider, 2017 - 2030 (USD Million)
7.4 Asia Pacific
7.4.1 Market size, by country, 2017 - 2030 (USD Million)
7.4.2 Market size, by product, 2017 - 2030 (USD Million)
7.4.2.1 Market size by equipment, 2017– 2030 (USD Million)
7.4.2.1.1 Market size by consumables, 2017– 2030 (USD Million)
7.4.2.2 Market size by media, 2017– 2030 (USD Million)
7.4.3 Market size, by application, 2017 - 2030 (USD Million)
7.4.3.1 Market size by Regenerative medicine, 2017– 2030 (USD Million)
7.4.3.2 Market size by biobanking, 2017– 2030 (USD Million)
7.4.4 Market size, by cell provider, 2017 - 2030 (USD Million)
7.4.5 China
7.4.5.1 Market size, by product, 2017 - 2030 (USD Million)
7.4.5.1.1 Market size by equipment, 2017– 2030 (USD Million)
7.4.5.1.1.1 Market size by consumables, 2017– 2030 (USD Million)
7.4.5.1.2 Market size by media, 2017– 2030 (USD Million)
7.4.5.2 Market size, by application, 2017 - 2030 (USD Million)
7.4.5.2.1 Market size by regenerative medicine, 2017– 2030 (USD Million)
7.4.5.2.2 Market size by biobanking, 2017– 2030 (USD Million)
7.4.5.3 Market size, by cell provider, 2017 - 2030 (USD Million)
7.4.6 Japan
7.4.6.1 Market size, by product, 2017 - 2030 (USD Million)
7.4.6.1.1 Market size by equipment, 2017– 2030 (USD Million)
7.4.6.1.1.1 Market size by consumables, 2017– 2030 (USD Million)
7.4.6.1.2 Market size by media, 2017– 2030 (USD Million)
7.4.6.2 Market size, by application, 2017 - 2030 (USD Million)
7.4.6.2.1 Market size by regenerative medicine, 2017– 2030 (USD Million)
7.4.6.2.2 Market size by biobanking, 2017– 2030 (USD Million)
7.4.6.3 Market size, by cell provider, 2017 - 2030 (USD Million)
7.4.7 India
7.4.7.1 Market size, by product, 2017 - 2030 (USD Million)
7.4.7.1.1 Market size by equipment, 2017– 2030 (USD Million)
7.4.7.1.1.1 Market size by consumables, 2017– 2030 (USD Million)
7.4.7.1.2 Market size by media, 2017– 2030 (USD Million)
7.4.7.2 Market size, by application, 2017 - 2030 (USD Million)
7.4.7.2.1 Market size by regenerative medicine, 2017– 2030 (USD Million)
7.4.7.2.2 Market size by biobanking, 2017– 2030 (USD Million)
7.4.7.3 Market size, by cell provider, 2017 - 2030 (USD Million)
7.4.8 Australia
7.4.8.1 Market size, by product, 2017 - 2030 (USD Million)
7.4.8.1.1 Market size by equipment, 2017– 2030 (USD Million)
7.4.8.1.1.1 Market size by consumables, 2017– 2030 (USD Million)
7.4.8.1.2 Market size by media, 2017– 2030 (USD Million)
7.4.8.2 Market size, by application, 2017 - 2030 (USD Million)
7.4.8.2.1 Market size by regenerative medicine, 2017– 2030 (USD Million)
7.4.8.2.2 Market size by biobanking, 2017– 2030 (USD Million)
7.4.8.3 Market size, by cell provider, 2017 - 2030 (USD Million)
7.4.9 South Korea
7.4.9.1 Market size, by product, 2017 - 2030 (USD Million)
7.4.9.1.1 Market size by equipment, 2017– 2030 (USD Million)
7.4.9.1.1.1 Market size by consumables, 2017– 2030 (USD Million)
7.4.9.1.2 Market size by media, 2017– 2030 (USD Million)
7.4.9.2 Market size, by application, 2017 - 2030 (USD Million)
7.4.9.2.1 Market size by regenerative medicine, 2017– 2030 (USD Million)
7.4.9.2.2 Market size by biobanking, 2017– 2030 (USD Million)
7.4.9.3 Market size, by cell provider, 2017 - 2030 (USD Million)
7.5 Latin America
7.5.1 Market size, by country, 2017 - 2030 (USD Million)
7.5.2 Market size, by product, 2017 - 2030 (USD Million)
7.5.2.1 Market size by equipment, 2017– 2030 (USD Million)
7.5.2.1.1 Market size by consumables, 2017– 2030 (USD Million)
7.5.2.2 Market size by media, 2017– 2030 (USD Million)
7.5.3 Market size, by application, 2017 - 2030 (USD Million)
7.5.3.1 Market size by Regenerative medicine, 2017– 2030 (USD Million)
7.5.3.2 Market size by biobanking, 2017– 2030 (USD Million)
7.5.4 Market size, by cell provider, 2017 - 2030 (USD Million)
7.5.5 Brazil
7.5.5.1 Market size, by product, 2017 - 2030 (USD Million)
7.5.5.1.1 Market size by equipment, 2017– 2030 (USD Million)
7.5.5.1.1.1 Market size by consumables, 2017– 2030 (USD Million)
7.5.5.1.2 Market size by media, 2017– 2030 (USD Million)
7.5.5.2 Market size, by application, 2017 - 2030 (USD Million)
7.5.5.2.1 Market size by regenerative medicine, 2017– 2030 (USD Million)
7.5.5.2.2 Market size by biobanking, 2017– 2030 (USD Million)
7.5.5.3 Market size, by cell provider, 2017 - 2030 (USD Million)
7.5.6 Mexico
7.5.6.1 Market size, by product, 2017 - 2030 (USD Million)
7.5.6.1.1 Market size by equipment, 2017– 2030 (USD Million)
7.5.6.1.1.1 Market size by consumables, 2017– 2030 (USD Million)
7.5.6.1.2 Market size by media, 2017– 2030 (USD Million)
7.5.6.2 Market size, by application, 2017 - 2030 (USD Million)
7.5.6.2.1 Market size by regenerative medicine, 2017– 2030 (USD Million)
7.5.6.2.2 Market size by biobanking, 2017– 2030 (USD Million)
7.5.6.3 Market size, by cell provider, 2017 - 2030 (USD Million)
7.6 Middle East & Africa
7.6.1 Market size, by country, 2017 - 2030 (USD Million)
7.6.2 Market size, by product, 2017 - 2030 (USD Million)
7.6.2.1 Market size by equipment, 2017– 2030 (USD Million)
7.6.2.1.1 Market size by consumables, 2017– 2030 (USD Million)
7.6.2.2 Market size by media, 2017– 2030 (USD Million)
7.6.3 Market size, by application, 2017 - 2030 (USD Million)
7.6.3.1 Market size by regenerative medicine, 2017– 2030 (USD Million)
7.6.3.2 Market size by biobanking, 2017– 2030 (USD Million)
7.6.4 Market size, by cell provider, 2017 - 2030 (USD Million)
7.6.5 South Africa
7.6.5.1 Market size, by product, 2017 - 2030 (USD Million)
7.6.5.1.1 Market size by equipment, 2017– 2030 (USD Million)
7.6.5.1.1.1 Market size by consumables, 2017– 2030 (USD Million)
7.6.5.1.2 Market size by media, 2017– 2030 (USD Million)
7.6.5.2 Market size, by application, 2017 - 2030 (USD Million)
7.6.5.2.1 Market size by regenerative medicine, 2017– 2030 (USD Million)
7.6.5.2.2 Market size by biobanking, 2017– 2030 (USD Million)
7.6.5.3 Market size, by cell provider, 2017 - 2030 (USD Million)
7.6.6 South Arabia
7.6.6.1 Market size, by product, 2017 - 2030 (USD Million)
7.6.6.1.1 Market size by equipment, 2017– 2030 (USD Million)
7.6.6.1.1.1 Market size by consumables, 2017– 2030 (USD Million)
7.6.6.1.2 Market size by media, 2017– 2030 (USD Million)
7.6.6.2 Market size, by application, 2017 - 2030 (USD Million)
7.6.6.2.1 Market size by regenerative medicine, 2017– 2030 (USD Million)
7.6.6.2.2 Market size by biobanking, 2017– 2030 (USD Million)
7.6.6.3 Market size, by cell provider, 2017 - 2030 (USD Million)
Chapter 8 Company Profiles
8.1 Competitive dashboard, 2021
8.2 Thermo Fisher Scientific, Inc.
8.2.1 Business overview
8.2.2 Financial data
8.2.3 Product landscape
8.2.4 Strategic outlook
8.2.5 SWOT analysis
8.3 Arctiko A/S
8.3.1 Business overview
8.3.2 Financial data
8.3.3 Product landscape
8.3.4 Strategic outlook
8.3.5 SWOT analysis
8.4 Cryport, Inc
8.4.1 Business overview
8.4.2 Financial data
8.4.3 Product landscape
8.4.4 Strategic outlook
8.4.5 SWOT analysis
8.5 PHC Holdings Corporation
8.5.1 Business overview
8.5.2 Financial data
8.5.3 Product landscape
8.5.4 Strategic outlook
8.5.5 SWOT analysis
8.6 Eppendorf AG
8.6.1 Business overview
8.6.2 Financial data
8.6.3 Product landscape
8.6.4 Strategic outlook
8.6.5 SWOT analysis
8.7 VWR International (Avantor, Inc.)
8.7.1 Business overview
8.7.2 Financial data
8.7.3 Product landscape
8.7.4 Strategic outlook
8.7.5 SWOT analysis
8.8 Helmer Scientific
8.8.1 Business overview
8.8.2 Financial data
8.8.3 Product landscape
8.8.4 Strategic outlook
8.8.5 SWOT analysis
8.9 Biolife solutions
8.9.1 Business overview
8.9.2 Financial data
8.9.3 Product landscape
8.9.4 Strategic outlook
8.9.5 SWOT analysis
8.10 Merck KGaA
8.10.1 Business overview
8.10.2 Financial data
8.10.3 Product landscape
8.10.4 Strategic outlook
8.10.5 SWOT analysis
8.11 Azenta
8.11.1 Business overview
8.11.2 Financial data
8.11.3 Product landscape
8.11.4 Strategic outlook
8.11.5 SWOT analysis
